The Prescribing Trends of Vitamin D Supplements and the Concurrent Use of Medicines for Chronic Conditions
Nehad J. Ahmed *
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Menshawy A. Menshawy
Department of Medicinal Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
*Author to whom correspondence should be addressed.
Abstract
Aim: This study aims to determine the prescribing patterns of vitamin D supplements in a public hospital in Al-Kharj.
Methodology: This cross-sectional drug utilization study was conducted at a public hospital in Al-Kharj that included a review of the outpatient electronic prescriptions in 2018. Therefore, inclusion criteria included the outpatient prescriptions that contain Vitamin D supplement in 2018. The data were collected using Microsoft Excel® and the descriptive data were represented as numbers and percentages.
Results: In 2018, 311 patients were prescribed Alfacalcidol. Most of the patients who received Alfacalcidol were females (76.21%), aging 40-69 (58.85%). The majority of Alfacalcidol drugs were prescribed by Internal Medicine department (56.91%). In 2018, 127 patients were received Cholecalciferol. Most of the patient were females (79.53%), in the age level between 30-39 (21.26%) followed by patients less than 10 years (18.90%). The majority of Cholecalciferol drugs were prescribed by Internal Medicine department (30.71%).
Conclusion: Vitamin D supplements were used frequently with other medicines for chronic conditions. More studies are needed to know the effect of Vitamin D supplements in the prevention or treatment of chronic diseases. Moreover, in order to use vitamin D supplements correctly, it is important to know the prescribing trends of these supplements.
Keywords: Prescribing patterns, prescribing trends, vitamin D, chronic conditions.